ResearcherUniversity of MichiganActive in the last 2 years
Liang Xu
Matched on ORCID iD 0000-0001-9196-4232; OpenAlex author ID A5052044401. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 34
2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 7
- KDM6A Promotes Angiogenesis, Migration, and Invasion of Pancreatic Cancer by Activating LAMP3. First author DOI 10.1615/critreveukaryotgeneexpr.2024054038↗
- An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Co-author DOI 10.1158/1535-7163.mct-19-0822↗
- Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition. Co-author DOI 10.1158/1541-7786.mcr-19-0589↗
- Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. Co-author PMID 31312365↗
- Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. Last author DOI 10.18632/oncotarget.7336↗
- ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-2289↗
- HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s. Last author DOI 10.1158/1078-0432.ccr-13-0621↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sunfu Fan · 1 shared paper, 2024 · strength 0.31
- Bingqi Yu · 1 shared paper, 2024 · strength 0.31
- Xiaoqing Wu · 4 shared papers, 2013–2020 · strength 0.29
- Paper An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer… DOI 10.1158/1535-7163.mct-19-0822↗
- Paper Therapeutic anti-CD147 antibody sensitizes cells to chemoradiotherapy via targeting pancreatic cancer stem cells. PMID 31312365↗
- Paper Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling. DOI 10.18632/oncotarget.7336↗
- Zhi‐Nan Chen · 2 shared papers, 2013–2019 · strength 0.12
- Kishore Polireddy · 1 shared paper, 2020 · strength 0.11
- Qi Chen · 1 shared paper, 2020 · strength 0.11
- Tao Wang · 1 shared paper, 2020 · strength 0.11
- Ruochen Dong · 1 shared paper, 2020 · strength 0.11
- Dan A. Dixon · 1 shared paper, 2020 · strength 0.11
- Jian‐Li Jiang · 1 shared paper, 2019 · strength 0.09
- Bin Wang · 1 shared paper, 2019 · strength 0.09
- Xinyu Fan · 1 shared paper, 2019 · strength 0.09
- Jiayuh Lin · 2 shared papers, 2013–2016 · strength 0.08
- Aditi Jain · 1 shared paper, 2019 · strength 0.08
- Teena Dhir · 1 shared paper, 2019 · strength 0.08
- Alex O. Haber · 1 shared paper, 2019 · strength 0.08
- Christopher William Schultz · 1 shared paper, 2019 · strength 0.08
- Talia Golan · 1 shared paper, 2019 · strength 0.08
- Samantha Z. Brown · 1 shared paper, 2019 · strength 0.08
- Chunhua Xi · 1 shared paper, 2019 · strength 0.08
- Jonathan Robert Brody · 1 shared paper, 2019 · strength 0.08
- James A. Posey · 1 shared paper, 2019 · strength 0.08
- Gloria Huei-Ting Su · 1 shared paper, 2019 · strength 0.08
- Michael Jon Pishvaian · 1 shared paper, 2019 · strength 0.08
- Charles J. Yeo · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.